{"name": "Cyclooxygenase Inhibitors", "ID": "N0000000160"}
{"name": "Lipoxygenase Inhibitors", "ID": "N0000000134"}
{"name": "Antigen Neutralization", "ID": "N0000184008"}
{"name": "Antibody-Receptor Interactions", "ID": "N0000009949"}
{"name": "Immunologic Adjuvants", "ID": "N0000000135"}
{"name": "Serotonin Agonists", "ID": "N0000000256"}
{"name": "Serotonin 1d Receptor Agonists", "ID": "N0000175764"}
{"name": "Serotonin 1b Receptor Agonists", "ID": "N0000175763"}
{"name": "Insulin Receptor Agonists", "ID": "N0000000225"}
{"name": "Vitamin K Inhibitors", "ID": "N0000175964"}
{"name": "Vitamin K Epoxide Reductase Inhibitors", "ID": "N0000000164"}
{"name": "Peroxisome Proliferator-activated Receptor alpha Agonists", "ID": "N0000175375"}
{"name": "Protein Synthesis Inhibitors", "ID": "N0000000150"}
{"name": "DNA Polymerase Inhibitors", "ID": "N0000020060"}
{"name": "Enzyme Inhibitors", "ID": "N0000000133"}
{"name": "Nucleic Acid Synthesis Inhibitors", "ID": "N0000000233"}
{"name": "Dopamine Uptake Inhibitors", "ID": "N0000000114"}
{"name": "Norepinephrine Uptake Inhibitors", "ID": "N0000000102"}
{"name": "Tubulin Interactions", "ID": "N0000010256"}
{"name": "Histamine H1 Receptor Antagonists", "ID": "N0000000190"}
{"name": "GABA A Modulators", "ID": "N0000000118"}
{"name": "GABA A Agonists", "ID": "N0000000196"}
{"name": "Immunologic Factor Interactions", "ID": "N0000000082"}
{"name": "Biological Macromolecular Activity", "ID": "N0000000142"}
{"name": "Full Opioid Agonists", "ID": "N0000175684"}
{"name": "Opioid Agonists", "ID": "N0000000174"}
{"name": "5-alpha Reductase Inhibitors", "ID": "N0000000126"}
{"name": "Phosphodiesterase 3 Inhibitors", "ID": "N0000175086"}
{"name": "Phosphodiesterase Inhibitors", "ID": "N0000000128"}
{"name": "Corticosteroid Hormone Receptor Agonists", "ID": "N0000175450"}
{"name": "Glucocorticoid Receptor Agonists", "ID": "N0000000159"}
{"name": "Nucleoside Reverse Transcriptase Inhibitors", "ID": "N0000009947"}
{"name": "Angiotensin-converting Enzyme Inhibitors", "ID": "N0000000181"}
{"name": "Electrolyte Activity", "ID": "N0000000220"}
{"name": "Dopamine Antagonists", "ID": "N0000000230"}
{"name": "Dopamine D2 Antagonists", "ID": "N0000175799"}
{"name": "Adrenergic alpha1-Antagonists", "ID": "N0000009919"}
{"name": "Monoamine Oxidase Inhibitors", "ID": "N0000000184"}
{"name": "Monoamine Oxidase-B Inhibitors", "ID": "N0000175761"}
{"name": "Topoisomerase Inhibitors", "ID": "N0000000176"}
{"name": "GABA A Receptor Interactions", "ID": "N0000000138"}
{"name": "GABA B Receptor Interactions", "ID": "N0000000204"}
{"name": "Enzyme Interactions", "ID": "N0000000163"}
{"name": "Cytochrome P450 2C9 Inducers", "ID": "N0000185507"}
{"name": "Cytochrome P450 2C19 Inducers", "ID": "N0000185607"}
{"name": "Cytochrome P450 2C8 Inducers", "ID": "N0000187063"}
{"name": "Cytochrome P450 2B6 Inducers", "ID": "N0000187064"}
{"name": "Cytochrome P450 3A Inducers", "ID": "N0000190118"}
{"name": "Sodium Channel Interactions", "ID": "N0000000180"}
{"name": "Cytochrome P450 2D6 Inducers", "ID": "N0000191267"}
{"name": "Cytochrome P450 1A2 Inducers", "ID": "N0000191266"}
{"name": "Antithrombins", "ID": "N0000000107"}
{"name": "Enzyme Activators", "ID": "N0000000231"}
{"name": "Serine Proteinase Inhibitors", "ID": "N0000000169"}
{"name": "Factor Xa Inhibitors", "ID": "N0000175635"}
{"name": "Unknown Cellular or Molecular Interaction", "ID": "N0000009915"}
{"name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", "ID": "N0000000121"}
{"name": "Acid-Base Activity", "ID": "N0000000226"}
{"name": "Adrenergic beta2-Agonists", "ID": "N0000009922"}
{"name": "Dopamine Agonists", "ID": "N0000000117"}
{"name": "Adrenergic alpha-Antagonists", "ID": "N0000000099"}
{"name": "P-Glycoprotein Inhibitors", "ID": "N0000185503"}
{"name": "Cytochrome P450 2C9 Inhibitors", "ID": "N0000185504"}
{"name": "Cytochrome P450 1A2 Inhibitors", "ID": "N0000182138"}
{"name": "Cytochrome P450 2D6 Inhibitors", "ID": "N0000182137"}
{"name": "Cytochrome P450 3A Inhibitors", "ID": "N0000190114"}
{"name": "Calcium Channel Antagonists", "ID": "N0000000069"}
{"name": "Adrenergic beta-Antagonists", "ID": "N0000000161"}
{"name": "Sodium Channel Antagonists", "ID": "N0000181004"}
{"name": "Potassium Channel Interactions", "ID": "N0000000211"}
{"name": "Structural Macromolecules", "ID": "N0000000228"}
{"name": "Estrogen Receptor Agonists", "ID": "N0000000100"}
{"name": "Adrenergic beta1-Antagonists", "ID": "N0000009923"}
{"name": "Adrenergic beta2-Antagonists", "ID": "N0000009924"}
{"name": "Alkalinizing Activity", "ID": "N0000009986"}
{"name": "Opioid Antagonists", "ID": "N0000000154"}
{"name": "Competitive Opioid Antagonists", "ID": "N0000175686"}
{"name": "Partial Opioid Agonists", "ID": "N0000175685"}
{"name": "Histamine Receptor Antagonists", "ID": "N0000000207"}
{"name": "Carbonic Anhydrase Inhibitors", "ID": "N0000000235"}
{"name": "Neurokinin 1 Antagonists", "ID": "N0000010262"}
{"name": "Cytochrome P450 2C19 Inhibitors", "ID": "N0000182140"}
{"name": "Cytochrome P450 3A4 Inhibitors", "ID": "N0000182141"}
{"name": "14-alpha Demethylase Inhibitors", "ID": "N0000020025"}
{"name": "Thrombin Inhibitors", "ID": "N0000009963"}
{"name": "Antithrombin Activators", "ID": "N0000009960"}
{"name": "Cytochrome P450 3A5 Inhibitors", "ID": "N0000190115"}
{"name": "Ergosterol Synthesis Inhibitors", "ID": "N0000009957"}
{"name": "Progestational Hormone Receptor Antagonists", "ID": "N0000000115"}
{"name": "Glucocorticoid Receptor Antagonists", "ID": "N0000000110"}
{"name": "Dipeptidyl Peptidase 4 Inhibitors", "ID": "N0000175912"}
{"name": "Serotonin 5HT-3 Antagonists", "ID": "N0000000090"}
{"name": "Serotonin 3 Receptor Antagonists", "ID": "N0000175817"}
{"name": "L-Calcium Channel Receptor Antagonists", "ID": "N0000020065"}
{"name": "Uncompetitive NMDA Receptor Antagonists", "ID": "N0000181819"}
{"name": "Sigma-1 Receptor Agonists", "ID": "N0000182147"}
{"name": "Serotonin Uptake Inhibitors", "ID": "N0000000109"}
{"name": "Sodium-Glucose Transporter 2 Inhibitors", "ID": "N0000187058"}
{"name": "Serotonin Antagonists", "ID": "N0000000130"}
{"name": "Adrenergic alpha-Agonists", "ID": "N0000000209"}
{"name": "Dopamine Receptor Interactions", "ID": "N0000000203"}
{"name": "Cytochrome P450 2B6 Inhibitors", "ID": "N0000182139"}
{"name": "Breast Cancer Resistance Protein Inhibitors", "ID": "N0000190113"}
{"name": "Potassium Channel Antagonists", "ID": "N0000175448"}
{"name": "Monoamine Oxidase-A Inhibitors", "ID": "N0000175760"}
{"name": "Chloride Channel Antagonists", "ID": "N0000000224"}
{"name": "Selective Estrogen Receptor Modulators", "ID": "N0000000168"}
{"name": "Sodium-Potassium Exchanging ATPase Interactions", "ID": "N0000000238"}
{"name": "Adrenergic alpha2-Agonists", "ID": "N0000009918"}
{"name": "Adrenergic alpha1-Agonists", "ID": "N0000009917"}
{"name": "Adrenergic beta1-Agonists", "ID": "N0000009921"}
{"name": "Phosphodiesterase 5 Inhibitors", "ID": "N0000020026"}
{"name": "Receptor Interactions", "ID": "N0000000085"}
{"name": "Bile-acid Binding Activity", "ID": "N0000175365"}
{"name": "M2 Protein Inhibitors", "ID": "N0000175542"}
{"name": "Ion Channel Interactions", "ID": "N0000000193"}
{"name": "Androgen Receptor Agonists", "ID": "N0000000146"}
{"name": "Alkylating Activity", "ID": "N0000000236"}
{"name": "alpha Glucosidase Inhibitors", "ID": "N0000000166"}
{"name": "Amylase Inhibitors", "ID": "N0000010274"}
{"name": "Cytochrome P450 3A4 Inducers", "ID": "N0000185506"}
{"name": "Para-Aminobenzoic Acid Inhibitors", "ID": "N0000009946"}
{"name": "Lipase Inhibitors", "ID": "N0000009916"}
{"name": "Guanylate Cyclase Activators", "ID": "N0000185499"}
{"name": "Nitric Oxide Donors", "ID": "N0000000120"}
{"name": "DNA Gyrase Inhibitors", "ID": "N0000020086"}
{"name": "Topoisomerase 4 Inhibitors", "ID": "N0000020087"}
{"name": "Cholinesterase Inhibitors", "ID": "N0000000177"}
{"name": "Calcium Channel Interactions", "ID": "N0000000140"}
{"name": "Cholinergic Muscarinic Antagonists", "ID": "N0000000125"}
{"name": "P2Y12 Receptor Antagonists", "ID": "N0000182143"}
{"name": "Cytochrome P450 2C8 Inhibitors", "ID": "N0000187062"}
{"name": "Transpeptidase Inhibitors", "ID": "N0000010215"}
{"name": "Free Radical Scavenging Activity", "ID": "N0000000170"}
{"name": "Non-Nucleoside Reverse Transcriptase Inhibitors", "ID": "N0000009948"}
{"name": "Organic Cation Transporter 2 Inhibitors", "ID": "N0000187061"}
{"name": "Folic Acid Metabolism Inhibitors", "ID": "N0000000111"}
{"name": "Dihydrofolate Reductase Inhibitors", "ID": "N0000000191"}
{"name": "Proton Pump Inhibitors", "ID": "N0000000147"}
{"name": "Bone Surface Interactions", "ID": "N0000009958"}
{"name": "Phosphate Chelating Activity", "ID": "N0000020074"}
{"name": "Adrenergic Agonists", "ID": "N0000000122"}
{"name": "Potassium Channel Openers", "ID": "N0000182728"}
{"name": "ATP-Binding Cassette (ABC) Transporter Interactions", "ID": "N0000000215"}
{"name": "GABA B Agonists", "ID": "N0000000116"}
{"name": "Tumor Necrosis Factor Receptor Blocking Activity", "ID": "N0000175451"}
{"name": "Peroxisome Proliferator-activated Receptor gamma Agonists", "ID": "N0000175377"}
{"name": "Thyroid Hormone Synthesis Inhibitors", "ID": "N0000175917"}
{"name": "Uncouplers", "ID": "N0000000155"}
{"name": "Organic Anion Transporter Interactions", "ID": "N0000000132"}
{"name": "Sodium Chloride Symporter Inhibitors", "ID": "N0000181005"}
{"name": "Neurotransmitter Transporter Interactions", "ID": "N0000000105"}
{"name": "Protein Kinase Inhibitors", "ID": "N0000175076"}
{"name": "Bcr-Abl Tyrosine Kinase Inhibitors", "ID": "N0000020009"}
{"name": "Cholinergic Antagonists", "ID": "N0000175370"}
{"name": "Androgen Receptor Antagonists", "ID": "N0000000243"}
{"name": "Transcription Factor Activity", "ID": "N0000000242"}
{"name": "Interleukin-6 Antagonists", "ID": "N0000191004"}
{"name": "Thymidylate Synthetase Inhibitors", "ID": "N0000000098"}
{"name": "Nucleoside Synthesis Inhibitors", "ID": "N0000175074"}
{"name": "Interleukin 6 Receptor Antagonists", "ID": "N0000190478"}
{"name": "HIV Protease Inhibitors", "ID": "N0000000246"}
{"name": "Norepinephrine Transporter Interactions", "ID": "N0000000234"}
{"name": "Serotonin Transporter Interactions", "ID": "N0000000167"}
{"name": "Topoisomerase 2 Inhibitors", "ID": "N0000020088"}
{"name": "Prostaglandin Receptor Antagonists", "ID": "N0000000108"}
{"name": "Aromatase Inhibitors", "ID": "N0000175080"}
{"name": "Leukotriene Receptor Antagonists", "ID": "N0000000083"}
{"name": "Cellular or Molecular Interactions", "ID": "N0000000223"}
{"name": "Angiotensin 2 Receptor Antagonists", "ID": "N0000000070"}
{"name": "Angiotensin 2 Type 1 Receptor Antagonists", "ID": "N0000180999"}
{"name": "beta Tubulin Interactions", "ID": "N0000010260"}
{"name": "Cytochrome P450 1A Inducers", "ID": "N0000191624"}
{"name": "Opioid mu-Receptor Agonists", "ID": "N0000191866"}
{"name": "Binding Activity", "ID": "N0000175355"}
{"name": "Calcineurin Inhibitors", "ID": "N0000175458"}
{"name": "UDP Glucuronosyltransferases Inhibitors", "ID": "N0000191269"}
{"name": "UGT1A1 Inhibitors", "ID": "N0000191272"}
{"name": "P-Glycoprotein Interactions", "ID": "N0000000239"}
{"name": "Histamine H2 Receptor Antagonists", "ID": "N0000000151"}
{"name": "Xanthine Oxidase Inhibitors", "ID": "N0000000206"}
{"name": "Glucagon-like Peptide-1 (GLP-1) Agonists", "ID": "N0000020058"}
{"name": "GABA A Antagonists", "ID": "N0000000074"}
{"name": "Increased Calcium-sensing Receptor Sensitivity", "ID": "N0000020081"}
{"name": "Antibody Interactions", "ID": "N0000010226"}
{"name": "Acetyl Aldehyde Dehydrogenase Inhibitors", "ID": "N0000000183"}
{"name": "Chelating Activity", "ID": "N0000000087"}
{"name": "Cytochrome P450 1A1 Inhibitors", "ID": "N0000193954"}
{"name": "Squalene Monooxygenase Inhibitors", "ID": "N0000010265"}
{"name": "Glucan Synthase Inhibitors", "ID": "N0000020027"}
{"name": "Glucagon Receptor Interactions", "ID": "N0000010275"}
{"name": "Physiochemical Activity", "ID": "N0000000065"}
{"name": "Serotonin Receptor Interactions", "ID": "N0000000198"}
{"name": "Somatostatin Receptor Agonists", "ID": "N0000000194"}
{"name": "Adrenergic alpha2-Antagonists", "ID": "N0000009920"}
{"name": "Adenosine Receptor Agonists", "ID": "N0000175788"}
